These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 482327)

  • 21. Renal lesions induced induced by tilorone and an analog. Ultrastructure and acid phosphatase study.
    Thelmo WL; Levine S
    Am J Pathol; 1978 May; 91(2):355-60. PubMed ID: 645830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
    Kooistra KL; Rodriguez M; Powis G
    Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of antiviral properties in mice of bis-pyrrolidinoacetamido-fluorenone (MLU-B75), bis-dipropylaminoacetamido-fluorenone (MLU-B76), and tilorone hydrochloride.
    Veckenstedt A; Witkowski W; Hoffmann S
    Acta Virol; 1979 Mar; 23(2):153-8. PubMed ID: 39439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of rifamycin and tilorone derivatives on Friend virus leukemia in mice.
    Rana MW; Pinkerton H; Rankin A
    Proc Soc Exp Biol Med; 1975 Oct; 150(1):32-5. PubMed ID: 1187708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of lymphokines by tilorone.
    Fahlbusch B; Zschiesche W; Schumann I; Tonew E
    Arch Immunol Ther Exp (Warsz); 1977; 25(5):701-5. PubMed ID: 339871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor activity of tilorone hydrochloride against some rodent tumors: preliminary report.
    Adamson RH
    J Natl Cancer Inst; 1971 Feb; 46(2):431-4. PubMed ID: 4329959
    [No Abstract]   [Full Text] [Related]  

  • 27. Antitumour effects of tilorone hydrochloride on the in vivo growth of chemically induced and spontaneously arising rat tumours.
    Basley WA; Rees RC; Greager JA; Baldwin RW
    Chemotherapy; 1981; 27(1):44-52. PubMed ID: 7215004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and activity evaluation of tilorone analogs as potential anticancer agents.
    Zhou D; Tuo W; Hu H; Xu J; Chen H; Rao Z; Xiao Y; Hu X; Liu P
    Eur J Med Chem; 2013 Jun; 64():432-41. PubMed ID: 23665799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Derivatives of benzo(c)fluorene. VI. Antiviral and interferon-inducing activities of three benzo(c)fluorenone derivatives in mice.
    Smejkal F; Zelená D; Krepelka J; Vancurová I
    Acta Virol; 1985 Jan; 29(1):11-8. PubMed ID: 2859757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential anticancer agents. 17. Analogues of methotrexate with a tripeptide side chain.
    Suster DC; Tărnăuceanu E; Botez G; Dobre V; Niculescu-Duvăz I
    J Med Chem; 1978 Nov; 21(11):1165-7. PubMed ID: 722723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Tilorone hydrochloride and congeners on reticuloendothelial system, tumors, and the immune response.
    Munson AE; Munson JA; Regelson W; Wampler GL
    Cancer Res; 1972 Jul; 32(7):1397-403. PubMed ID: 5063975
    [No Abstract]   [Full Text] [Related]  

  • 32. The basis for the disparate sensitivity of L1210 leukemia and Walker 256 carcinoma to a new triazine folate antagonist.
    Skeel RT; Sawicki WL; Cashmore AR; Bertino JR
    Cancer Res; 1973 Nov; 33(11):2972-6. PubMed ID: 4748449
    [No Abstract]   [Full Text] [Related]  

  • 33. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity.
    Finch RA; Shyam K; Penketh PG; Sartorelli AC
    Cancer Res; 2001 Apr; 61(7):3033-8. PubMed ID: 11306484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cancerostatically active 6,6a,7,8,13,13a-hexahydro-1-benzopyrano[4,3-b]-1,5-benzodiazepine diastereoisomers (author's transl)].
    Werner W; Jungstand W; Gutsche W; Wohlrabe K; Römer W; Tresselt D
    Pharmazie; 1979 Jul; 34(7):394-7. PubMed ID: 504329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of tilorone on immunoglobulin-bearing lymphocytes (B cells) in peripheral blood and spleens of mice.
    Raychaudhuri A; Megel H
    J Reticuloendothel Soc; 1976 Aug; 20(2):127-34. PubMed ID: 1085368
    [No Abstract]   [Full Text] [Related]  

  • 36. Characterization of tilorone-induced mouse migration inhibitory factor by affinity chromatography and isoelectric focusing.
    Fahlbusch B; Zschiesche W; Römer W
    Acta Biol Med Ger; 1981; 40(2):147-52. PubMed ID: 7023160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-Lymphocyte depletion induced in rats by analogs of tilorone hydrochloride.
    Levine S; Sowinski R; Albrecht WL
    Toxicol Appl Pharmacol; 1977 Apr; 40(1):137-45. PubMed ID: 301296
    [No Abstract]   [Full Text] [Related]  

  • 38. Potentiation by clofibrate of in-vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 carcinosarcoma.
    Gold J
    Cancer Biochem Biophys; 1978; 3(1):41-5. PubMed ID: 552898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents.
    Keller HJ; Keppler B; Schmähl D
    Arzneimittelforschung; 1982; 32(8):806-7. PubMed ID: 6890355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antineoplastic and curative antileukemic activity of 1,4-benzoquinone guanylhydrazone thiosemicarbazone and its hydrochloride on in vivo murine models].
    Gutsche W; Schulze W; Jungstand W; Wohlrabe K
    Pharmazie; 1983 Feb; 38(2):105-7. PubMed ID: 6856662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.